ghk-cu peptide safety human use 5 GHK Cu Peptide Injection
Description
In the gut, it brought failing muscle valves back toward normal pressure
Jensen I
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
It also aids in weight loss by boosting metabolism and contributes to improved skin quality and appearance
